SARS2 and COVID-19: Altogether, our study provides evidence to support the claim that host cell determines glycosylation, implying that the glycosylation of SARS2 from COVID-19 patients could be different from those expressed by other hosts, and further suggesting that mRNA vaccines36 that involve S antigens produced by recipients themselves but not by other hosts could be more effective on combating COVID-19.